D. Medical has recruited its Scientific Advisory Board exclusively from global top - tier experts in the field of diabetes, under the leadership of its Medical Director, Prof. Moshe Philip, M.D, Professor of Pediatrics specializing in Pediatric Endocrinology at the Sackler Faculty of Medicine at Tel-Aviv University who is closely involved with the development and design of our products.

 

Moshe Phillip, MD is a professor of pediatrics specializing in pediatric endocrinology at the Sackler Faculty of Medicine at Tel-Aviv University, or Sackler, and holds the Irene and Nicholas Marsh Chair in Endocrinology and Diabetes. Dr. Phillip is active in both clinical and basic research. Since 1997, he has also served as the director of the Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes at Schneider Children’s Medical Center of Israel, which is affiliated with Sackler. Between 1992 and 1997, he served as division head at the Pediatric Diagnostic and Therapeutic Center at Soroka Medical Center Ben Gurion University Beer-Sheba. Previously, he served as head of the School for Continuing Education at Sackler and since 2006 as Vice Dean for Research and Development of Tel-Aviv University. He received his MD degree from Ben Gurion University in 1983 and specialized in pediatric endocrinology between 1989 and 1992 at the University of Maryland School of Medicine in Baltimore. Professor Phillip is a member of national organizations, such as the Israeli Medical Association and the Israeli National Committee for Child Health Care. He chaired the committee of Type 1 diabetes at the National Council for Diabetes. Professor Phillip is the author of close to 200 publications, is serving as a member of the editorial boards of several Israeli and international journals and is a reviewer for more than 15 journals.


Paul S. Strumph is Vice President, Therapeutic Strategy Lead, Cardiovascular / Metabolic at Quintiles Transnational, a fully integrated bio pharmaceutical services company offering Clinical, Commercial, Consulting and Capital solutions worldwide. He has led or co-led development teams responsible for first-in-human to post-approval phase IV studies with Bristol-Myers Squibb & Co., Merck KGaA, and GlaxoSmithKline. With over ten years of experience assuming roles of increasing responsibility in clinical research and development in diabetes and related fields, his perspectives have included small to large pharma based in and outside the U.S., device development, and non-profit clinical leadership at the Juvenile Diabetes Research Foundation. Dr. Strumph is one of the few people who achieved certification in four board specialties: Internal Medicine, Pediatrics, Adult Endocrinology Diabetes and Metabolism, and Pediatric Endocrinology.  After fellowship he practiced adult and pediatric endocrinology for six years in Asheville, NC and served on the adjunct faculty at UNC, Chapel Hill. He is an author of more than a dozen articles in scientific journals and magazines, including Nature, Clinical Pediatrics, The Journal of Clinical Endocrinology and Metabolism, and Diabetes Care.



Satish K. Garg, MD, MBBS, DM is a professor of medicine and pediatrics at the Young Adult Clinic of the Barbara Davis Center for Diabetes of the University of Colorado School of Medicine in Denver, Colorado. His research interests include the early detection and treatment of renal and retinal complications of Type 1 diabetes and the development of new diagnostic and therapeutic tools related to clinical diabetes management that include, among others, new insulin analogs and glucose sensors. Dr. Garg received a medical degree in internal medicine from Punjab University in Ludhiana, India, where he also completed a residency in internal medicine at Christian Medical College and Hospitals. He completed fellowships in adult endocrinology and diabetes at the Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh, India, and in pediatric endocrinology and diabetes at the University of Colorado at Denver and Health Sciences Center. He is board certified in internal medicine and endocrinology and diabetes. Dr. Garg is the editor in-chief of the Diabetes Technology and Therapeutics Journal and chair of the planning committee for Clinical Therapeutics and New Technology area for the 2007 and 2008 Annual American Diabetes Associations meetings. He is a member of the International Diabetes Federation, the American Diabetes Association, the Endocrine Society of India, the European Association for the Study of Diabetes, the Regional Pediatric Endocrine Society of Colorado, the Research Society for the Study of Diabetes Mellitus, and numerous other professional societies in both the United States and India. He is an international lecturer and speaker and has published more than 177 original manuscripts in peer-reviewed journals.


Tadej Battelino, MD obtained his MD at the Ljubljana Medical Faculty in 1990, where he also passed his board exam in pediatrics. In 1993 and 1994, he completed a clinical fellowship in pediatric endocrinology at Loyola University of Chicago, Illinois, USA. After obtaining his PhD, he completed a postdoctoral fellowship in 1996 and 1997 at Hôpital Robert Debré and INSERM U-457, Paris, France. He is currently a tenured professor of pediatrics at the Ljubljana Medical Faculty and head of the pediatric endocrinology, diabetes and metabolism department at the UMC-University Children’s Hospital Ljubljana, Slovenia. He acted as principal investigator for several competitive research projects from the Slovenian National Research Agency, participated in trials sponsored by the European Association for the Study of Diabetes, in two EU-sponsored research projects and in many other international clinical and basic research projects. His publications include basic and clinical research papers on diabetes, pediatric endocrinology, metabolism and genetics. He is a member of many Slovenian and international professional societies, including the ESPE, EASD, ADA and ISPAD. He is co-organizer of the annual meetings of the Advanced Technologies and Treatment of Diabetes. He was a guest lecturer at Vienna and Tel Aviv Universities and at many international meetings and symposia. He serves as editor of the European Journal of Endocrinology and as reviewer for international peer-reviewed journals and international grant committees.



Jan Bolinder, MD is a professor in clinical diabetology at the Karolinska Institutet and chairman of the Department of Medicine at the Karolinska University Hospital Huddinge in Stockholm, Sweden. He earned his MD in 1977 and his PhD in Medicine in 1983 at the Karolinska Institutet and holds specialist degrees in internal medicine and endocrinology and diabetology. Dr. Bolinder has almost two decades of experience with the microdialysis technique primarily with respect to studies of human adipose tissue and skeletal muscle metabolism in vivo and also in the development of the technique as a clinical tool for continuous glucose monitoring in patients with diabetes mellitus. He has authored more than 150 articles and reviews in peer-reviewed journals within the field of clinical/experimental diabetology and metabolism. His main areas of research interest include molecular and cellular mechanisms underlying insulin resistance in adipose tissue and skeletal muscle, clinical glucose monitoring, islet and pancreas transplantation, and epidemiology.